KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, the first on-demand oral ...

KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug for a type of hereditary ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Hot flashes are a menopausal hallmark: Up to 80 percent of women have them. But numerous lesser-known symptoms are also ...

WASHINGTON — The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s ...

Planned submission of IND application in 2025; Phase 1 clinical trial to follow if IND application approved No new PTSD drug ...

This summer, the U.S. Department of Agriculture (USDA) is finalizing new national rules for labeling and marketing lab-grown ...

Lexeo Therapeutics received a breakthrough therapy designation from the Food and Drug Administration for its treatment for Friedreich's ataxia. Ataxia is a rare, inherited disease that damages the ...

The system is used with CT scans to develop a 3D surgical plan to help ensure an accurate hip replacement surgery ...

KalVista Pharmaceuticals Announces FDA Approval of EKTERLY® (sebetralstat), First and Only Oral On-demand Treatment for ...

Regeneron Pharmaceuticals’ Lynozyfic (linvoseltamab-gcpt) has been granted accelerated approval by the US Food and Drug ...

The drug gained a following in some circles for its supposed ability to treat COVID-19 safely, something all major medical ...